Agent Capital, LLC
agentcapital.com Direct investor
Agent Capital is a healthcare venture capital firm that invests in novel therapeutics and treatments across all stages of development, focusing on areas with high unmet medical need such as rare diseases, oncology, neurology, and immunology.
Agent Capital, LLC is a venture capital firm headquartered in Waltham, United States. It invests directly in companies, from seed to growth, in rare Diseases, oncology, neurology and immunology. 35 portfolio companies, as it reports.
“Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.”
— Agent Capital, LLC, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Waltham, United States
- Sectors
- Rare Diseases, Oncology, Neurology, Immunology
- Portfolio
- 35 companies
Team, as Agent Capital, LLC publishes it
- Geeta Vemuri Managing Partner, Founder
- Preston Noon Partner, Co-Founder
- Anthony DiNatale Vice President
- Kirti Nimmala Investment Associate
- Venkata Aditya Kalaga Investment Analyst
- Bruce Peacock Operating Partner
- John Orloff Venture Partner
- John Glasspool Venture Partner
- Julie Gionfriddo Head of Investor Relations and Fundraising
- Marla McMillan VP of Fund Finance
- Lisa Kraeutler VP of Fund Finance
- Lori Forrest Controller
Names and roles exactly as listed on agentcapital.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 28 co-investors found.
- OrbiMed 3 shared companies: cyrusbio.com, q32bio.com, star-therapeutics.com
- CU Healthcare Innovation Fund 2 shared companies: q32bio.com, foresight-dx.com
- Double Point Ventures 2 shared companies: cerevance.com, foresight-dx.com
- Foresite Capital 2 shared companies: cerevance.com, foresight-dx.com
- 1315 Capital 2 shared companies: nu-tekbiosciences.com, primrosebio.com
- Basis Set Ventures 1 shared company: vergegenomics.com
- Great Oaks Venture Capital 1 shared company: vergegenomics.com
- Lifeforce Capital Management, LLC 1 shared company: vergegenomics.com
- Anzu Partners 1 shared company: cyrusbio.com
- Argonautic Ventures 1 shared company: cyrusbio.com
and 18 more — the graph.
Where this comes from
Every fact above was read from a page Agent Capital, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.agentcapital.com/name, is_investor, type, hq_country, hq_city, sectors, thesis_quote, thesis_quote_page, description, status
- https://www.agentcapital.com/about/layer, people
- https://www.agentcapital.com/strategy/stage_min, stage_max
- https://www.agentcapital.com/portfolio/portfolio_count
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 3916 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- Cancer Focus FundVenture capital · Houston, United States
- MassVenturesVenture capital · Seed – Series A · Waltham, United States
- MPM BioImpactVenture capital · Seed – Growth · Boston, United States
- Norwich VenturesVenture capital · Seed – Series A · Waltham, United States
- .406 VenturesVenture capital · Seed – Series A · Boston, United States